Avita Medical | 1811094D - Market Capitalization


Avita Medical reported AUD152.75M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Mayne Pharma AUD 252.67M 153.55M Dec/2025
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nanosonics AUD 1.2B 25.43M Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pacific Edge NZD 177.94M 49.22M Jun/2026
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
Pharma Mar EUR 1.57B 225M Mar/2026
Polynovo AUD 849.74M 24.18M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Qiagen NV USD 8.27B 1.62B Mar/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 52.52B 12.57B Dec/2025
Sartorius EUR 14.25B 2.16B Mar/2026
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025
Zealand Pharma A/S 33.35B 448.34M Dec/2025